PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Qventus receives $30M investment to bring AI to hospital workflows


The company said in a statement that it plans to use the new money to expand its platform, which uses artificial intelligence to improve hospital workflows.
Healthcare management tech platform Qventus has announced that it landed $30 million Series B funding in a round led by Bessemer Venture Partners, with participation from New York-Presbyterian Hospital, Mayfield Fund, and Northwest Venture Partners. This latest funding round brings the Mountain View California startup to a total of $43 million in funding.
The company said in a statement that it plans to use the new money to expand its platform, which uses artificial intelligence to improve hospital workflows.
“Hospitals are under tremendous pressure to increase efficiency, improve margins, and enhance patient experience, all while reducing the burden on frontline teams, and they currently lack tools to use data to achieve operational productivity gains,” Stephen Kraus, a partner at Bessemer Venture who will be joining Qventus’ board, said in a statement. “Qventus is the first to effectively use AI/[machine learning] to solve this real operational need in hospitals with clear ROI. We believe Qventus will become the leading logistical operating system for hospitals by turning healthcare data into insights, and turning these insights into action.”
Qventus’ AI-based software will predict potential issues and offer immediate logistical recommendations to health teams, mitigating workflow issues and, according to the company, saving hospitals money.
“Health systems have increasingly complex operations; for them, operational excellence depends on empowering real-time decision making by thousands of disparate employees,” Qventus CEO and cofounder Mudit Garg said in a statement. “This financing provides us with the opportunity to expand our ability to enable decisions across the enterprise and continue to deliver on positive outcomes for our innovative customers and their patients.”
The company launched in 2011 under the name analyticsMD, and changed its name to Qventus in March of last year. According to a statement, Qventus has so far enabled more than 3.8 million patient encounters, and has been deployed at NewYork-Presbyterian Hospital, Emory Healthcare, and the Mercy health system, among other providers.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026